New research at the University of Guelph offers renewed hope for both human and animal patients fighting osteosarcoma. This ...
Advancements in chemotherapy and immunotherapy have improved multiple myeloma survival rates, with 5-year relative survival increasing from 37.7% to 60.3% between 2000-2004 and 2015-2019. Treatment ...
BEIJING -- China's pediatric and adolescent cancer patients have achieved a 5-year survival rate of 77.2 percent, marking ...
A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in ...